Investor Centre

Pharmaxis Ltd (ASX: PXS) held an online investor briefing by chief executive officer Mr Gary Phillips on July 12 2023.

The event consisted of a short presentation on the final interim analysis of data from patients from the PXS-5505 Phase 2 cancer trial, followed by a Q&A session from attendees.

View the presentation slides here